These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18187400)

  • 1. Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases.
    Brauck K; Zenge MO; Vogt FM; Quick HH; Stock F; Trarbach T; Ladd ME; Barkhausen J
    Radiology; 2008 Mar; 246(3):910-6. PubMed ID: 18187400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing metallic artifacts in postoperative spinal imaging: usefulness of IDEAL contrast-enhanced T1- and T2-weighted MR imaging--phantom and clinical studies.
    Cha JG; Jin W; Lee MH; Kim DH; Park JS; Shin WH; Yi BH
    Radiology; 2011 Jun; 259(3):885-93. PubMed ID: 21386053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body MR imaging: evaluation of patients for metastases.
    Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
    Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and performance evaluation of simultaneous PET/MR whole-body imaging with continuous table motion.
    Braun H; Ziegler S; Lentschig MG; Quick HH
    J Nucl Med; 2014 Jan; 55(1):161-8. PubMed ID: 24232869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
    Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
    Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of the inner ear and cerebellopontine angle: comparison of three-dimensional and two-dimensional sequences.
    Czerny C; Rand T; Gstoettner W; Woelfl G; Imhof H; Trattnig S
    AJR Am J Roentgenol; 1998 Mar; 170(3):791-6. PubMed ID: 9490977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
    Golfieri R; Cherryman GR; Olliff JF; Husband JE
    Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
    Coulam CH; Chan FP; Li KC
    AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
    Merkle EM; Nour SG; Lewin JS
    Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parametrial infiltration of cervix carcinoma: diagnostic value of contrast-enhanced fat-suppressed T1-weighted SE sequences at 1.5 tesla].
    Scheidler J; Heuck A; Wencke K; Kimmig R; Müller-Lisse U; Reiser M
    Rofo; 1997 Apr; 166(4):312-6. PubMed ID: 9198495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel application of T1-weighted BLADE sequences with fat suppression compared to TSE in contrast-enhanced T1-weighted imaging of the neck: cutting-edge images?
    Finkenzeller T; Zorger N; Kühnel T; Paetzel C; Schuierer G; Stroszczynski C; Fellner C
    J Magn Reson Imaging; 2013 Mar; 37(3):660-8. PubMed ID: 23034901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
    Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.